Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 24, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
FORE Biotherapeutics Secures $38 Million in Series D-2 Financing to Advance Plixorafenib Clinical Trials
Life Sciences Times
-
May 22, 2025
0
Venture Capital
WellTheory Secures $5M to Scale AI-Powered Autoimmune Care Nationwide
Life Sciences Times
-
May 22, 2025
0
Venture Capital
Dementia Discovery Fund Closes Second Fund at $269M to Accelerate Innovation in Dementia Treatments
Life Sciences Times
-
May 20, 2025
0
Venture Capital
Instem Acquires Strong Tower Solutions to Boost Clinical Statistical Computing Offerings
Life Sciences Times
-
May 20, 2025
0
Venture Capital
Carlyle, SK Capital, and bluebird bio Issue Revised Tender Instructions Following Deal Amendment
Life Sciences Times
-
May 17, 2025
0
Venture Capital
STAAR Surgical Authorizes $30 Million Share Repurchase Program, Signaling Confidence in Future Growth
Life Sciences Times
-
May 16, 2025
0
Medtech
Akido Secures $60 Million Series B to Scale ScopeAI, Its Breakthrough AI System for Healthcare
Life Sciences Times
-
May 16, 2025
0
Venture Capital
NanoVibronix Prices $10 Million Public Offering of Preferred Stock and Warrants
Life Sciences Times
-
May 15, 2025
0
Venture Capital
Kincell Bio Secures $22 Million Investment Led by NewSpring Capital and Kineticos Life Sciences, Adds Industry Veteran Pete Buzy to Board
Life Sciences Times
-
May 15, 2025
0
Venture Capital
VILAS Ventures Backs $13.5M Series A3 Round for CND Life Sciences to Accelerate Neurodegenerative Diagnostics
Life Sciences Times
-
May 14, 2025
0
Venture Capital
Denali Growth Partners Closes $400 Million Second Fund to Back High-Growth, Capital-Efficient Companies
Life Sciences Times
-
May 13, 2025
0
Venture Capital
Jaanuu Acquired by VentureOn Management in Strategic Asset Sale
Life Sciences Times
-
May 8, 2025
0
1
...
15
16
17
...
115
Page 16 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026